Investing Legend Hints the End May Be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis Precision Medicines stock fluctuated after reporting mixed results for their drug vormatrigine in treating focal onset seizures.
Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React
Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved Inspire V system.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
RFK Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON (AP) — Health Secretary is vowing to “fix” the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by .
Questions emerge about NYC gunman's mental health and his security-sensitive job in Las Vegas
LAS VEGAS (AP) — The man who stormed a Manhattan office tower with a gun, before killing himself, worked in the surveillance department of a Las Vegas casino, part of an industry built on watching for threats before they unfold.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Some workers would be excluded from student loan forgiveness program for 'illegal' activity
WASHINGTON (AP) — Teachers, social workers, nurses and other public workers would be cut off from a popular if the Trump administration finds their employer engaged in activities with a “substantial illegal purpose,” under a new federal proposal released on Friday.
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst
Eli Lilly's pricing strategy for GLP-1 drugs is expected to have minimal margin impact, with BofA reaffirming a $900 price target.
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Kellogg says it will remove artificial dyes from cereals by the end of 2027
NEW YORK (AP) — WK Kellogg Co. plans to remove artificial dyes in the next two and a half years, according to the company and the attorney general of Texas. The maker of Froot Loops and Apple Jacks gave the timeline as U.S. food producers face increasing pressure from the U.S. government and consumers to from their products.
White House Eyes Up to 250% Drug Tariffs In Bid To Reclaim US Pharma Supply Chain
White House trade adviser Peter Navarro discusses tariffs on pharma imports under a "Section 232" trade investigation.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern on board to fill in gaps.
Don't Touch Tesla Stock Without Reading This First - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
US at plastics treaty talks is rare international participation under Trump. What's the goal?
Under President Donald Trump's leadership, the United States has withdrawn from international negotiations and commitments, particularly around climate. But the U.S. is very much involved in treaty talks for a global accord to end plastic pollution.
France’s top court strikes down pesticide clause in farming law
PARIS (AP) — France’s highest court on Thursday blocked a key part of a contentious farming law that would have brought back a banned pesticide.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Trump once hailed mRNA vaccines as a 'medical miracle.' Now RFK Jr. is halting advancement
WASHINGTON (AP) — President hailed as a “medical miracle” the mRNA vaccines developed to combat the deadly in 2020.
Compounded GLP-1s And Competition Force Novo Nordisk To Slash Outlook
Novo Nordisk reported Q2 sales of $11.7 billion, missing consensus. Sales increased by 13% in Danish kroner, driven by GLP-1 diabetes and obesity care sales.
Major Investors Bet Big on This "Unlisted" Stock - Ad
When the former Zillow exec whose first venture sold for $120M starts a new company, people notice. No wonder the VCs behind Uber and eBay also backed Pacaso. Their platform sells fractions of premier properties, rewriting a $1.3T market. And it works, earning over $110M in gross profit to date.
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
BioMarin beats Q2 expectations on strong enzyme therapy sales and raises full-year earnings and revenue guidance amid continued Voxzogo growth.
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
TG Therapeutics missed Q2 earnings and revenue expectations but raised its 2025 Briumvi sales guidance following strong global growth.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
AMA and other medical associations are kicked out of CDC vaccine workgroups
NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations.
Asian shares retreat after Trump's order imposing new tariffs on 68 countries and the EU
MANILA, Philippines (AP) — Asian shares retreated Friday following that saw more losses as investors assess President Donald Trump's order in seven days.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses
CVS Health topped Wall Street expectations for the second quarter and hiked its , as the health care giant continued to rally under new management from a forgettable 2024.
Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy
Teva raised 2025 guidance for Austedo, Ajovy, and Uzedy after Q2 earnings beat estimates, despite missing revenue expectations.
The Surprising New Date That Could Fuel the AI Boom - Ad
Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.
UnitedHealth Hit By $6.5 Billion Medical Cost Blowout: Launches AI-Led Overhaul, Drops 600K Members To Regain Margins — 'These Are Serious Challenges'
Healthcare company, UnitedHealth Group Inc. (NYSE: UNH), says that it will drop 600,000 Medicare Advantage members and launch a sweeping operational overhaul after being blindsided by $6.5 billion in unanticipated medical costs.
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and broad patient impact.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025
UnitedHealth missed Wall Street’s second-quarter earnings expectations and offered an updated, and conservative take on the rest of 2025.
Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state
LITTLE ROCK, Ark. (AP) — A federal judge temporarily blocked on Monday Arkansas' first-in-the-nation law that pharmacy benefit managers from owning pharmacies in the state.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
EU regulator approves injectable HIV drug that experts say could help stop transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.